Therefore, therapeutic strategies targeting NO in stroke must consider this complexity, aiming to inhibit detrimental NO production (mainly iNOS, possibly excessive nNOS) while preserving or enhancing beneficial eNOS function. Here, NOS1 is linked to Stroke.